United States · FDA National Drug Code directory
nilotinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-239_13b46e09-62d2-4ce9-b3c0-deafcb1f1842
- Product NDC
- 72205-239
- Form
- CAPSULE
- Composition / generic term
- nilotinib
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251119
- Source listing expiry
- 20261231
Source-listed ingredients
- NILOTINIB — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 CAPSULE in 1 BLISTER PACK (72205-239-63) · 72205-239-63
- 4 BLISTER PACK in 1 CARTON (72205-239-64) / 28 CAPSULE in 1 BLISTER PACK · 72205-239-64
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →